Corbus Pharmaceuticals Reports Quarterly Results Ended June 30, 2026

What Happened
Corbus Pharmaceuticals Holdings, Inc. announced on August 6, 2026 that it issued a press release disclosing financial information and operating metrics for the fiscal quarter ended June 30, 2026 and discussed its business outlook. The company filed the information on Form 8-K (Item 2.02) and attached the press release as Exhibit 99.1.

Key Details

• Press release date and 8-K filing: August 6, 2026.
• Reporting period: fiscal quarter ended June 30, 2026.
• The press release with the results and outlook is furnished as Exhibit 99.1 to the Form 8-K.
• The Form 8-K was signed on behalf of the company by CEO Yuval Cohen.

Why It Matters
This 8-K delivers the company’s latest quarterly results and operating metrics and provides management’s short-term business outlook—information investors use to assess recent performance, cash runway, and near-term prospects. Retail investors should read the attached press release (Exhibit 99.1) for specific numbers on revenue, expenses, cash position, and any guidance or forward-looking commentary the company provided.